Efficacy of Fluoxetine - a Trial in Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

October 20, 2014

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Stroke
Interventions
DRUG

Fluoxetine

Fluoxetine 20mg once daily for 6 months.

DRUG

Placebo

Matching placebo.

Trial Locations (1)

171 76

Karolinska Institutet, Stockholm

All Listed Sponsors
collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Swedish Heart Lung Foundation

OTHER

collaborator

Stroke-Riksförbundet

UNKNOWN

collaborator

Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse

UNKNOWN

collaborator

Hjärnfonden (The Swedish Brain foundation)

UNKNOWN

collaborator

The Swedish Medical Association

OTHER

lead

Karolinska Institutet

OTHER

NCT02683213 - Efficacy of Fluoxetine - a Trial in Stroke | Biotech Hunter | Biotech Hunter